Skip to main content

Peer Review reports

From: Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

Original Submission
5 Apr 2018 Submitted Original manuscript
9 Jun 2018 Reviewed Reviewer Report - Raheleh Roudi
10 Jul 2018 Reviewed Reviewer Report - Reviewer 2
29 Jul 2018 Reviewed Reviewer Report - Hidehito Horinouchi
11 Aug 2018 Author responded Author comments - Motoko Tachihara
Resubmission - Version 2
11 Aug 2018 Submitted Manuscript version 2
22 Aug 2018 Reviewed Reviewer Report - Raheleh Roudi
27 Aug 2018 Reviewed Reviewer Report - Reviewer 2
6 Sep 2018 Reviewed Reviewer Report - Hidehito Horinouchi
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
13 Sep 2018 Editorially accepted
3 Oct 2018 Article published 10.1186/s12885-018-4819-2

You can find further information about peer review here.

Back to article page